Literature DB >> 19710435

Development of a pharmacist-managed latent tuberculosis clinic.

Julie P Last1, Janet M Kozakiewicz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710435     DOI: 10.2146/ajhp090034

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  4 in total

1.  Improving Palivizumab Compliance rough a Pharmacist-Managed RSV Prevention Clinic.

Authors:  Jennifer W Chow; Michael F Chicella; Anthony M Christensen; Carolyn S Moneymaker; John Harrington; James E Dice
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Sep-Oct

2.  Implementation of Isoniazid Preventive Therapy among People Living with HIV in Northwestern Nigeria: Completion Rate and Predictive Factors.

Authors:  Abiola Victor Adepoju; Chidubem L Ogbudebe; Olusola Adedeji Adejumo; Johnson Okolie; Jude O Inegbeboh
Journal:  J Glob Infect Dis       Date:  2020-05-22

3.  House calls by community health workers and public health nurses to improve adherence to isoniazid monotherapy for latent tuberculosis infection: a retrospective study.

Authors:  Alicia H Chang; Andrea Polesky; Gulshan Bhatia
Journal:  BMC Public Health       Date:  2013-09-28       Impact factor: 3.295

4.  Addressing Latent Tuberculosis Infection Treatment Through a Collaborative Care Model With Community Pharmacies and a Health Department.

Authors:  Bernadette Jakeman; Stefanie J Logothetis; Melissa H Roberts; Amy Bachyrycz; Diana Fortune; Matthew E Borrego; Julianna Ferreira; Marcos Burgos
Journal:  Prev Chronic Dis       Date:  2020-02-13       Impact factor: 2.830

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.